Psyence Biomedical in Spotlight After Trump’s Ibogaine Order Puts Supply Strategy to the Test
Psyence Biomedical Ltd., which trades on the Nasdaq, caught attention after President Donald Trump signed an order on April 18 aimed at accelerating research…

















